申请人:The Upjohn Company
公开号:US04438130A1
公开(公告)日:1984-03-20
Mono-Oxa-, thiaspirocyclic-benzene-acetamide and -benzamide compounds of the formula ##STR1## wherein p, n, m, A, E, R, R.sub.1, R.sub.2, X, Y and Z are as defined in the specification, e.g., (.+-.)-(5.alpha.,7.alpha.,9.beta.)-3,4-dichloro-N-methyl-N-[7-(1-pyrrolidi nyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide, and the pharmacologically acceptable salts thereof, are useful as analgesic compounds having low physical dependence liability, compared to morphine and methodone, and low dysphoria side effects. Some of these compounds have potent analgesic activity when administered orally, and some have low CNS sedative side effects. Pharmaceutical compositions and methods for using these compounds as analgesics are disclosed. Processes for preparing this class of compounds are also disclosed.
本发明涉及一类单氧-、硫杂-和螺环苯乙酰胺和苯甲酰胺化合物,其化学式为##STR1##其中p、n、m、A、E、R、R.sub.1、R.sub.2、X、Y和Z如说明书中所定义,例如(.+-.)-(5.alpha.,7.alpha.,9.beta.)-3,4-二氯-N-甲基-N-[7-(1-吡咯烷基)-1-氧杂螺[4.5]癸-8-基]苯乙酰胺及其药学上可接受的盐,作为镇痛化合物具有低的身体依赖性,相比吗啡和美沙酮,以及低的情绪低落副作用。这些化合物中的一些在口服给药时具有强效的镇痛活性,而一些则具有低的中枢神经系统镇静副作用。本发明还公开了将这些化合物作为镇痛剂的制药组合物和方法。本发明还公开了制备这类化合物的方法。